Switzerland's Ferring Pharma has reached an agreement to buy US women's health start-up Gameto for...
Inovio Pharma's plasmid DNA-based immunotherapy Voceryq has been approved in the US for adults with...
While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that...
In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of...
Eli Lilly has added another arrow to the quiver of its new diabetes and weight-loss...
The prospectus for Anthropic's IPO, which could take place in November and be the largest-ever...
US Health Secretary Robert F Kennedy Jr has pushed ahead with a policy to allow...
Hutchmed and AstraZeneca's Orpathys is now under review in Europe and Japan for MET-driven, EGFR-mutated...
Each year, more than one million people in the US receive chemotherapy, a standard treatment...
Smart ring manufacturer Oura has launched a clinical trial to see if data collected from...
Eli Lilly has shrugged off any concerns about the effect of US drug pricing policies...
Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal...
Geopolitical instability is shaking the operating foundations of the pharmaceutical industry. Wars and regional conflicts...
The appetite for Nasdaq listings shows no signs of letting up, with Aspen Neuroscience and...
A patient-led initiative for rare disease hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix...
